u/line_petrov
Contributes reviews on supplier material. Based in Hyderabad.
member · joined 12 Mar 2025
Comments — page 3 of 3
comment on someone explain prior authorization to me like I have not read a paper in years in c/insurancefights · 51 points · 2 years ago
document what has been tried and for how long, that is the whole case
comment on [Question] heart rate — what am I missing here in c/sideeffects · 479 points · 2 years ago
sulphur burps are unpleasant and they are not dangerous
comment on [Discussion] we are measuring appeal at the wrong time and calling it noise in c/insurancefights · 1 points · 2 years ago
Kept a log with every date, name of department and reference number. When they claimed no record of a call, I had the reference.
comment on [Vendor] QST vs WWB on the same compound, same month — both cleared 99.0% in c/tirzepatide · 188 points · 2 years ago
The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.
comment on Spain: copay, and what it actually costs here in c/insurancefights · 103 points · 2 years ago
New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January.
comment on genuine question about reflux that I am slightly embarrassed to ask in c/sideeffects · 189 points · 2 years ago
holding a dose an extra month is a legitimate answer to bad tolerance
comment on unpopular opinion: most of what gets said here about GIP is guesswork in c/tirzepatide · 3 points · 2 years ago
Held 7.5 for five months. Everyone kept asking when I was going to 10. The answer was never, because 7.5 was working.
comment on [Discussion] fatigue is doing more work than we give it credit for in c/sideeffects · -31 points · 2 years ago
A symptom that begins the day after the shot and fades by day four tracks the exposure curve. One that appears at random in week 76 probably does not, and that is worth saying to a clinician rather than to us.
comment on Mounjaro is the most under-discussed thing on this board in c/tirzepatide · 324 points · 2 years ago
Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.
comment on nobody warned me about fatigue and I would have liked the warning in c/sideeffects · 70 points · 2 years ago
smaller meals, earlier, is the boring advice that works